Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Adrenergic α₁A Receptor (ADRA1A) is a G protein-coupled receptor that primarily responds to adrenaline and noradrenaline. It mediates smooth muscle contraction in various tissues, including blood vessels, urethral sphincter, and iris dilator muscle. It also plays a role in cognitive function and neurotransmission within the central nervous system. Drugs targeting this receptor are used to treat hypertension and benign prostatic hyperplasia.
Agonist-induced activation of Gq/11 proteins, leading to activation of phospholipase C (PLC) and increased intracellular calcium levels; Antagonist-induced blockade of receptor activation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic α₁A Receptor.